相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Flavin adenine dinucleotide content of quinone reductase 2: Analysis and optimization for structure-function studies
Kevin Ka Ki Leung et al.
ANALYTICAL BIOCHEMISTRY (2012)
Autophagy modulation as a potential therapeutic target for diverse diseases
David C. Rubinsztein et al.
NATURE REVIEWS DRUG DISCOVERY (2012)
New insights into mechanisms of therapeutic effects of antimalarial agents in SLE
Daniel J. Wallace et al.
NATURE REVIEWS RHEUMATOLOGY (2012)
Flavin Redox Switching of Protein Functions
Donald F. Becker et al.
ANTIOXIDANTS & REDOX SIGNALING (2011)
Insights into the redox cycle of human quinone reductase 2
Karine Reybier et al.
FREE RADICAL RESEARCH (2011)
Identification of a Lysosomal Pathway That Modulates Glucocorticoid Signaling and the Inflammatory Response
Yuanzheng He et al.
SCIENCE SIGNALING (2011)
XDS
Wolfgang Kabsch
ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY (2010)
PHENIX: a comprehensive Python-based system for macromolecular structure solution
Paul D. Adams et al.
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY (2010)
Chloroquine activates the p53 pathway and induces apoptosis in human glioma cells
Ella L. Kim et al.
NEURO-ONCOLOGY (2010)
Pyrimidine biosynthesis links mitochondrial respiration to the p53 pathway
Anastasia A. Khutornenko et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Mechanism of Flavin Reduction and Oxidation in the Redox-Sensing Quinone Reductase Lot6p from Saccharomyces cerevisiae
Sonja Sollner et al.
BIOCHEMISTRY (2009)
Quinone reductase acts as a redox switch of the 20S yeast proteasome
Sonja Sollner et al.
EMBO REPORTS (2009)
Primaquine revisited six decades after its discovery
Nuno Vale et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2009)
Chloroquine and its analogs: A new promise of an old drug for effective and safe cancer therapies
V. Raja Solomon et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2009)
New roles of flavoproteins in molecular cell biology: An unexpected role for quinone reductases as regulators of proteasomal degradation
Sonja Sollner et al.
FEBS JOURNAL (2009)
Functional polymorphisms, altered gene expression and genetic association link NRH:quinone oxidoreductase 2 to breast cancer with wild-type p53
Ke-Da Yu et al.
HUMAN MOLECULAR GENETICS (2009)
The structure of the leukemia drug imatinib bound to human quinone reductase 2 (NQO2)
Jonathan A. Winger et al.
BMC STRUCTURAL BIOLOGY (2009)
Nicotinic acid nicotinamide and nicotinamide riboside: A molecular evaluation of NAD(+) precursor vitamins in human nutrition
Katrina L. Bogan et al.
ANNUAL REVIEW OF NUTRITION (2008)
Kinetic, thermodynamic and X-ray structural insights into the interaction of melatonin and analogues with quinone reductase 2
Barbara Calamini et al.
BIOCHEMICAL JOURNAL (2008)
Second-line salvage treatment of AIDS-associated Pneumocystis jirovecii pneumonia -: A case series and systematic review
Thomas Benfield et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2008)
An unbiased evaluation of CK2 inhibitors by chemoproteomics
James S. Duncan et al.
MOLECULAR & CELLULAR PROTEOMICS (2008)
Chemical proteomic profiles of the BCR-ABL inhibitors imatinib, nilotinib, and dasatinib, reveal novel kinase and nonkinase targets
Uwe Rix et al.
BLOOD (2007)
Deficiency of NRH:Quinone oxidoreductase 2 differentially regulates TNF signaling in keratinocytes:: Up-regulation of apoptosis correlates with down-regulation of cell survival kinases
Kwang Seok Ahn et al.
CANCER RESEARCH (2007)
Structural basis for light-dependent signaling in the dimeric LOV domain of the photosensor YtvA
Andreas Moeglich et al.
JOURNAL OF MOLECULAR BIOLOGY (2007)
被撤回的出版物: NRH:Quinone oxidoreductase 2 and NAD(P)H:quinone oxidoreductase 1 protect tumor suppressor p53 against 20S proteasomal degradation leading to stabilization and activation of p53 (Retracted article. See vol. 75, pg. 615, 2015)
Xing Gong et al.
CANCER RESEARCH (2007)
Conformational switching in the fungal light sensor vivid
Brian D. Zoltowski et al.
SCIENCE (2007)
UK malaria treatment guidelines
David G. Lalloo et al.
JOURNAL OF INFECTION (2007)
Scaling and assessment of data quality
P Evans
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY (2006)
Characterization of the melatoninergic MT3 binding site on the NRH:quinone oxidoreductase 2 enzyme
F Mailliet et al.
BIOCHEMICAL PHARMACOLOGY (2005)
p53 proteasomal degradation - Poly-ubiquitination is not the whole story
G Asher et al.
CELL CYCLE (2005)
Kinetic mechanism of quinone oxidoreductase 2 and its inhibition by the antimalarial quinolines
JJ Kwiek et al.
BIOCHEMISTRY (2004)
Ferriprotoporphyrin IX, phospholipids, and the antimalarial actions of quinoline drugs
CD Fitch
LIFE SCIENCES (2004)
Crystal structure of quinone reductase 2 in complex with resveratrol
L Buryanovskyy et al.
BIOCHEMISTRY (2004)
Proteome-wide identification of cellular targets affected by bisindolylmaleimide-type protein kinase C inhibitors
D Brehmer et al.
MOLECULAR & CELLULAR PROTEOMICS (2004)
Discovery of novel targets of quinoline drugs in the human purine binding proteome
PR Graves et al.
MOLECULAR PHARMACOLOGY (2002)
Disruption of dihydronicotinamide riboside:quinone oxidoreductase 2 (NQO2) leads to myeloid hyperplasia of bone marrow and decreased sensitivity to menadione toxicity
DJ Long et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
分享论文
